|
Prior to joining Summer Street Research Partners, Matt Dormer worked for Wellington Management Company in the Portfolio Advisor Group and was formerly an associate analyst covering the biotechnology sector at Fulcrum Global Partners in New York City. Prior to his experience in biotech equity research, Mr. Dormer was a scientist for a start-up biotech company, and a research associate and teaching fellow at Harvard University, where he conducted research on tumor suppressor genes. Dormer has an MBA in finance from Northeastern University and a BS in Biology from Davidson College. | 